Forum · Medicine · Story discussion
Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease
This randomized trial assesses the effect of oral nicotinamide riboside treatment for 52 weeks vs placebo on clinical outcomes among patients with early Parkinson disease.
3 days ago — JAMA · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…